Author:
Kojima Yasuyuki,Kawamoto Hisanori,Nishikawa Toru,Hayami Ryosuke,Shimo Arata,Haku Ei,Akiyama Kyoko,Tsugawa Koichiro
Reference26 articles.
1. Paclitaxel after doxorubicin plus cyclophosphamide as adjuvant chemotherapy for node-positive breast cancer: Results from NSABP B-28;Mamounas;J Clin Oncol,2005
2. Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer;Sparano;N Engl J Med,2008
3. Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks;Green;J Clin Oncol,2005
4. Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): An open-label, 2×2 factorial randomised phase 3 trial;Earl;Lancet Oncol,2014
5. NCCN Clinical Practice Guidelines in Oncology: Breast Cancer. Version3,2017